These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8721771)

  • 1. Prevention of decline in renal function in the diabetic db/db mouse.
    Cohen MP; Clements RS; Cohen JA; Shearman CW
    Diabetologia; 1996 Mar; 39(3):270-4. PubMed ID: 8721771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy.
    Cohen MP; Sharma K; Jin Y; Hud E; Wu VY; Tomaszewski J; Ziyadeh FN
    J Clin Invest; 1995 May; 95(5):2338-45. PubMed ID: 7738197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin.
    Cohen MP; Hud E; Wu VY
    Kidney Int; 1994 Jun; 45(6):1673-9. PubMed ID: 7933815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse.
    Cohen MP; Masson N; Hud E; Ziyadeh F; Han DC; Clements RS
    Exp Nephrol; 2000; 8(3):135-43. PubMed ID: 10810230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy.
    Cohen MP; Ziyadeh FN
    J Am Soc Nephrol; 1996 Feb; 7(2):183-90. PubMed ID: 8785386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice.
    Cohen MP; Hud E; Shea E; Shearman CW
    Metabolism; 2002 Jul; 51(7):901-5. PubMed ID: 12077739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.
    Ziyadeh FN; Hoffman BB; Han DC; Iglesias-De La Cruz MC; Hong SW; Isono M; Chen S; McGowan TA; Sharma K
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8015-20. PubMed ID: 10859350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of renal function abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy.
    Cohen MP; Clements RS; Hud E; Cohen JA; Ziyadeh FN
    Exp Nephrol; 1996; 4(3):166-71. PubMed ID: 8773479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
    Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
    FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-beta1.
    Cohen MP; Ziyadeh FN; Hong SW; Shearman CW; Hud E; Lautenslager GT; Iglesias-de la Cruz MC; Chen S
    Kidney Int; 2002 Jun; 61(6):2025-32. PubMed ID: 12028443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.
    Flyvbjerg A; Dagnaes-Hansen F; De Vriese AS; Schrijvers BF; Tilton RG; Rasch R
    Diabetes; 2002 Oct; 51(10):3090-4. PubMed ID: 12351452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.
    Cohen MP; Chen S; Ziyadeh FN; Shea E; Hud EA; Lautenslager GT; Shearman CW
    Kidney Int; 2005 Oct; 68(4):1554-61. PubMed ID: 16164632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice.
    Cohen MP; Lautenslager GT; Shearman CW
    Metabolism; 2001 Dec; 50(12):1435-40. PubMed ID: 11735089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated albumin promotes a generalized vasculopathy in the db/db mouse.
    Cohen MP; Clements RS; Cohen JA; Shearman CW
    Biochem Biophys Res Commun; 1996 Jan; 218(1):72-5. PubMed ID: 8573179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system.
    Ziyadeh FN; Han DC; Cohen JA; Guo J; Cohen MP
    Kidney Int; 1998 Mar; 53(3):631-8. PubMed ID: 9507208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urocortin ameliorates diabetic nephropathy in obese db/db mice.
    Li X; Hu J; Zhang R; Sun X; Zhang Q; Guan X; Chen J; Zhu Q; Li S
    Br J Pharmacol; 2008 Jul; 154(5):1025-34. PubMed ID: 18587447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice.
    Chen S; Iglesias-de la Cruz MC; Jim B; Hong SW; Isono M; Ziyadeh FN
    Biochem Biophys Res Commun; 2003 Jan; 300(1):16-22. PubMed ID: 12480514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice.
    Clements RS; Robison WG; Cohen MP
    J Diabetes Complications; 1998; 12(1):28-33. PubMed ID: 9442812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of diabetic nephropathy between male and female eNOS
    Ma Y; Li W; Yazdizadeh Shotorbani P; Dubansky BH; Huang L; Chaudhari S; Wu P; Wang LA; Ryou MG; Zhou Z; Ma R
    Am J Physiol Renal Physiol; 2019 May; 316(5):F889-F897. PubMed ID: 30810354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice.
    Shibuya K; Kanasaki K; Isono M; Sato H; Omata M; Sugimoto T; Araki S; Isshiki K; Kashiwagi A; Haneda M; Koya D
    Diabetes; 2005 Mar; 54(3):838-45. PubMed ID: 15734863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.